Insider Shareholders with Direct Ownership of Nuvalent, Inc. (NUVL)
This section provides a comprehensive overview of the insiders with direct ownership of Nuvalent, Inc. (NUVL). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Nuvalent, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
| 2,499 | 740,000 | 1,427,197 $126 Million | 25 |
Jun 12, 2024
Added 0.17%
|
|
|
Wellington Biomedical Innovation Master Investors (Cayman) I L.P.
> 10% Shareholder |
897,671 | 0 | 897,671 $79.4 Million | 1 |
Aug 02, 2021
Added 50.0%
|
|
James Richard Porter
President and CEO |
139,800 | 27,000 | 188,113 $16.6 Million | 3 |
Oct 15, 2024
Reduced 0.43%
|
|
Christopher Durant Turner
Chief Medical Officer |
71,373 | 23,560 | 47,813 $4.23 Million | 14 |
Jan 05, 2024
Added 41.05%
|
|
Darlene Noci
Chief Development Officer |
230,500 | 197,200 | 33,300 $2.95 Million | 69 |
Oct 01, 2024
Reduced 0.52%
|
|
Deborah Ann Miller
Chief Legal Officer |
183,846 | 150,546 | 33,300 $2.95 Million | 57 |
Sep 16, 2024
Reduced 0.89%
|
|
Alexandra Balcom
Chief Financial Officer |
128,300 | 95,000 | 33,300 $2.95 Million | 13 |
Sep 30, 2024
Reduced 8.17%
|
|
Henry E. Pelish
Chief Scientific Officer |
13,100 | 43,295 | 33,300 $2.95 Million | 3 |
Sep 16, 2024
Reduced 0.3%
|
| 39,166 | 36,667 | 2,507 $221,844 | 13 |
Aug 23, 2024
Reduced 57.08%
|
|
| 2,499 | 0 | 2,499 $221,136 | 1 |
Jun 12, 2024
Added 50.0%
|
|
| 2,499 | 0 | 2,499 $221,136 | 1 |
Jun 12, 2024
Added 50.0%
|
|
| 2,499 | 0 | 2,499 $221,136 | 1 |
Jun 12, 2024
Added 50.0%
|
|
| 2,499 | 0 | 2,499 $221,136 | 1 |
Jun 12, 2024
Added 50.0%
|
|
| 2,499 | 0 | 2,499 $221,136 | 1 |
Jun 12, 2024
Added 50.0%
|
|
| 2,499 | 0 | 2,499 $221,136 | 1 |
Jun 12, 2024
Added 50.0%
|
|
| 7,499 | 5,000 | 2,499 $221,136 | 3 |
Jun 12, 2024
Added 50.0%
|